Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes

Medicine and Dentistry

• Antivirus Agent 25%
• Autoimmune Skin Disease 25%
• Blocking Antibody 25%
• Cell Surface 25%
• Cetuximab 25%
• Contact Allergy 25%
• Dermatitis 25%
• Epidermal Growth Factor Receptor 100%
• Epidermal Growth Factor Receptor Kinase Inhibitor 75%
• Flow Cytometry 25%
• Immunohistochemistry 25%
• In Vitro 25%
• Keratinocyte 50%
• Keratinocyte Cell Line 25%
• Lung Transplantation 25%
• Malignant Neoplasm 25%
• Protein Expression 100%
• Quantitative Reverse Transcription Polymerase Chain Reaction 25%
• Serositis 25%
• Skin Biopsy 50%
• Tyrosine-Kinase Inhibitor 25%

Immunology and Microbiology

• Autoimmune Skin Disease 9%
• Blocking Antibody 9%
• Cell Surface 9%
• Cetuximab 9%
• CIITA 9%
• Contact Allergy 9%
• Dermatitis 9%
• Epidermal Growth Factor 100%
• Inflammation Response 9%
• Keratinocyte 18%
• Keratinocyte Cell Line 9%
• Lung Transplantation 9%
• MHC Class I 100%
• MHC Class II 100%
• Protein Expression 36%
• Quantitative Reverse Transcription Polymerase Chain Reaction 9%

Keyphrases

• Alveolar Damage 10%
• Autoimmune Skin Disease 10%
• CIITA 10%
• EGFR Ligands 10%
• EGFRI 40%
• Immune-related Adverse Effects 20%
• Inflammatory Immune Response 10%
• MHC Class I Gene 100%
• MHC Class II Genes 100%
• MHC Expression 10%
• Quantitative Real-time 10%